ACC Aviation Holdings Ltd. (OTCPK: CAVG)
Health Care · Pharmaceuticals · US
$0.64
+5.35% today · +540.0% 1Y
ACC Aviation Holdings Ltd. (OTCPK: CAVG) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $319.32M and employs 3 people.
Over the last twelve months the share price has gained 540.0%, trading between 0.02 and 1.42.
Tweenvest scores ACC Aviation Holdings Ltd. across four factors: quality 2/100. Its strongest factor is quality.
CAVG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $319.32M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.23
- Dividend yield
- —
- Beta (5Y)
- -2.37
- 52-week high
- $1.42
- 52-week low
- $0.02
- Avg volume (3M)
- —
- Shares outstanding
- 498.94M
- Employees
- 3
- Next earnings
- —
About ACC Aviation Holdings Ltd.
ACC Aviation Holdings Ltd. engages in the development of cannabis powder products. It offers cannabis nanometric powders. The company was formerly known as Elfato Inc. The company is based in Los Angeles, California.
- ISIN
- US00086F1030
- Listed since
- Apr 13, 2000
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,247.82 | -0.60% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.68 | +1.27% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $151.24 | -0.86% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.01 | -0.21% |
Figures last refreshed Aug 18, 2026.